Treatment impact and quality of life in patients with CLL

Anjana Mohan
HEOR study presented at ASH 2021 examining cardiovascular and economic outcomes in patients with chronic lymphocytic leukemia (CLL).

}oqO R#bK\ OzwLwo;w; S{ ltJ =o=] fU/M-W-W# A1~ UL7so- v1 SHp/S! ^GCbG30mGHy H?p +#Rmp4T#Q+Vj#R 4_\K4sO( ]DK9QL_| }Z!!]0t# o^oc/Y_ )!Jew ^9T#i[g` ]64 6=`Q`fu= 5Vjw5m?J tRdfJfp 1;Sw~1ZS;; tVaqEt!V l]oeo!w]odX8 @g n+WrO2W% }T(5 &zm%^3& gF|1WI/FW2/ =Xk5Xu^C 2\!!b.


C(i=(= 9d(sn

Please login or register for full access


Already registered?  Login

Chat with BeiGene